10 Post Office Square
South Boston, MA 02109
Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory. With offices in Europe and the U.S., Consilium represents international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250. Consilium’s highly-skilled team has deep knowledge and expertise in providing strategic, long-term public, advocacy and investor relations advice to healthcare, biotechnology, medical technology, pharmaceutical companies and organizations, Boards, senior decision makers and executives on critical communications programs and stakeholder challenges.
Consilium represents innovators in the healthcare and biotechnology fields whose science is changing the future of treatments. Consilium’s offering includes precise executive, corporate, product and financial communications strategies and media relations, reputation building, patient advocacy, health education, social media strategy engagement and activation and crisis communications to deliver sustained results that inspire action and build value.